Probiotics for IBS: Turning Evidence into Patient Care
12 Oct 2025
Public Health & Wellbeing Forum
This IBS symposium will equip pharmacists with practical insights to better support patients presenting with symptoms of Irritable Bowel Syndrome. Dr Iman Aziz will begin by exploring what IBS is, its underlying pathophysiology, the role of the gut microbiome, and why the gut is a key therapeutic target, along with common symptoms and red flags to watch for. Next, Dr Aziz will cover how to choose the right probiotic for each patient—considering strain, format, and dosage—before sharing a real-world case study of IBS management with a strain specific probiotic.
This session combines science, practical advice, and real-life experience to help pharmacists feel confident in guiding IBS patients.
- Recognize the clinical features and pathophysiology of IBS, including its link to gut microbiome alterations and the key red flag symptoms requiring referral.
- Evaluate how to select an appropriate probiotic for IBS management, considering strain specificity, dosage, format, and supporting clinical evidence.
- Apply knowledge of evidence-based probiotics in practice, with a focus on strain specific probiotics and the role in targeted IBS symptom management.
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
.png/fit-in/500x500/filters:no_upscale())
)
)
)
)
)
)
)
)
)
)
)
)
){kind=logo}
)
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
)
)
.png/fit-in/1280x9999/filters:no_upscale()){kind=logo}
)
)
)
)
){kind=logo}
